Trial Outcomes & Findings for Endostapler Hemostasis Study (NCT NCT04149925)

NCT ID: NCT04149925

Last Updated: 2021-02-23

Results Overview

Intraoperative staple line bleeding as measured by the provided bleeding severity scale (1: No bleeding; 2: Minimal bleeding; 3: Moderate bleeding; 4: Excessive bleeding; 5: Profuse bleeding)

Recruitment status

COMPLETED

Target enrollment

60 participants

Primary outcome timeframe

10 seconds after last staple line

Results posted on

2021-02-23

Participant Flow

Participant milestones

Participant milestones
Measure
AEON Endostapler
Stapling performed by AEON Endostapler AEON Endostapler: Surgery with AEON Endostapler
Echelon Flex Powered Stapler
Stapling performed by Echelon Flex Powered Stapler Echelon Flex Powered Stapler: Surgery with Echelon Flex Powered Stapler
Overall Study
STARTED
30
30
Overall Study
COMPLETED
30
30
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
AEON Endostapler
n=30 Participants
Stapling performed by AEON Endostapler AEON Endostapler: Surgery with AEON Endostapler
Echelon Flex Powered Stapler
n=30 Participants
Stapling performed by Echelon Flex Powered Stapler Echelon Flex Powered Stapler: Surgery with Echelon Flex Powered Stapler
Total
n=60 Participants
Total of all reporting groups
Age, Continuous
46 years
STANDARD_DEVIATION 11 • n=30 Participants
45 years
STANDARD_DEVIATION 11 • n=30 Participants
46 years
STANDARD_DEVIATION 11 • n=60 Participants
Sex: Female, Male
Female
18 Participants
n=30 Participants
25 Participants
n=30 Participants
43 Participants
n=60 Participants
Sex: Female, Male
Male
12 Participants
n=30 Participants
5 Participants
n=30 Participants
17 Participants
n=60 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
BMI
44 kg/m^2
STANDARD_DEVIATION 6 • n=30 Participants
46 kg/m^2
STANDARD_DEVIATION 7 • n=30 Participants
45 kg/m^2
STANDARD_DEVIATION 7 • n=60 Participants

PRIMARY outcome

Timeframe: 10 seconds after last staple line

Intraoperative staple line bleeding as measured by the provided bleeding severity scale (1: No bleeding; 2: Minimal bleeding; 3: Moderate bleeding; 4: Excessive bleeding; 5: Profuse bleeding)

Outcome measures

Outcome measures
Measure
AEON Endostapler
n=30 Participants
Stapling performed by AEON Endostapler AEON Endostapler: Surgery with AEON Endostapler
Echelon Flex Powered Stapler
n=30 Participants
Stapling performed by Echelon Flex Powered Stapler Echelon Flex Powered Stapler: Surgery with Echelon Flex Powered Stapler
Staple Line Bleeding
2.08 score on a scale
Standard Deviation .98
2.57 score on a scale
Standard Deviation 1.13

SECONDARY outcome

Timeframe: 1 month following procedure

Incidence of postoperative leakage during one-month monitoring period following procedure

Outcome measures

Outcome measures
Measure
AEON Endostapler
n=30 Participants
Stapling performed by AEON Endostapler AEON Endostapler: Surgery with AEON Endostapler
Echelon Flex Powered Stapler
n=30 Participants
Stapling performed by Echelon Flex Powered Stapler Echelon Flex Powered Stapler: Surgery with Echelon Flex Powered Stapler
Staple Line Leaking
Yes
0 Participants
0 Participants
Staple Line Leaking
No
30 Participants
30 Participants

SECONDARY outcome

Timeframe: 1 month following procedure

Incidence of reported device-related adverse events

Outcome measures

Outcome measures
Measure
AEON Endostapler
n=30 Participants
Stapling performed by AEON Endostapler AEON Endostapler: Surgery with AEON Endostapler
Echelon Flex Powered Stapler
n=30 Participants
Stapling performed by Echelon Flex Powered Stapler Echelon Flex Powered Stapler: Surgery with Echelon Flex Powered Stapler
Adverse Events
Yes
0 Participants
0 Participants
Adverse Events
No
30 Participants
30 Participants

SECONDARY outcome

Timeframe: During surgery

Incidence of product malfunction during procedure

Outcome measures

Outcome measures
Measure
AEON Endostapler
n=30 Participants
Stapling performed by AEON Endostapler AEON Endostapler: Surgery with AEON Endostapler
Echelon Flex Powered Stapler
n=30 Participants
Stapling performed by Echelon Flex Powered Stapler Echelon Flex Powered Stapler: Surgery with Echelon Flex Powered Stapler
Product Malfunction
Yes
0 Participants
0 Participants
Product Malfunction
No
30 Participants
30 Participants

SECONDARY outcome

Timeframe: Within 72 hours of surgery start

Incidence of intraoperative or postoperative blood transfusion within 72 hours of surgery start time

Outcome measures

Outcome measures
Measure
AEON Endostapler
n=30 Participants
Stapling performed by AEON Endostapler AEON Endostapler: Surgery with AEON Endostapler
Echelon Flex Powered Stapler
n=30 Participants
Stapling performed by Echelon Flex Powered Stapler Echelon Flex Powered Stapler: Surgery with Echelon Flex Powered Stapler
Blood Transfusion
Yes
0 Participants
0 Participants
Blood Transfusion
No
30 Participants
30 Participants

SECONDARY outcome

Timeframe: 1 week following procedure

Postoperative pain level as measured by a standard pain severity scale of 0-10 where 0 means no pain and 10 means severe pain.

Outcome measures

Outcome measures
Measure
AEON Endostapler
n=30 Participants
Stapling performed by AEON Endostapler AEON Endostapler: Surgery with AEON Endostapler
Echelon Flex Powered Stapler
n=30 Participants
Stapling performed by Echelon Flex Powered Stapler Echelon Flex Powered Stapler: Surgery with Echelon Flex Powered Stapler
Pain Level
1.8 score on a scale
Standard Deviation 2.9
1.6 score on a scale
Standard Deviation 2.7

Adverse Events

AEON Endostapler

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Echelon Flex Powered Stapler

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Annette Dunn

Lexington Medical Inc.

Phone: 480-313-8505

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place